AUS
NZ
UK
CA
USA
IND
Highlights
- Zions Bancorporation acquires a significant stake in Johnson & Johnson during the first quarter
- Multiple firms expand positions in alongside growing sector interest
- Johnson & Johnson posts higher quarterly revenue with improved year-over-year results
Johnson & Johnson, a major entity in the healthcare sector, is part of the Dow Jones Industrial Average. Zions Bancorporation National Association UT expanded its position in the company during the first quarter, as disclosed in a recent SEC filing. The acquisition adds to Johnson & Johnson’s standing among institutional portfolios.
Broader Institutional Participation
Several other firms increased their exposure to (NYSE:JNJ) over recent months. Highline Wealth Partners LLC expanded its share count, while von Borstel & Associates Inc. initiated a new position. Additional entities, including Capital A Wealth Management LLC, Harvest Fund Management Co. Ltd, and Accredited Wealth Management LLC, also entered or expanded in the stock. These movements underscore ongoing activity within the healthcare equity space.
Stock Performance and Key Metrics
Shares of opened near recent highs, maintaining a consistent upward trajectory over the past year. The stock’s valuation metrics reflect steady earnings and a market capitalization above the four-hundred-billion-dollar mark. Moving averages over both medium and long time frames remain aligned with the broader positive trend. Balance sheet strength is evident through a debt-to-equity ratio below one, alongside current and quick ratios maintaining operational liquidity.
Johnson & Johnson’s latest quarterly report showed earnings per share above consensus expectations. Revenue for the period exceeded the prior-year quarter, driven by increased demand across product categories. The company’s net margin remains strong, and return on equity continues to be among the highest in the sector. This quarter also marked growth in both top-line and bottom-line performance compared to the same period last year.
Market Ratings
Recent broker coverage on (NYSE:JNJ) reflects mixed sentiment, with some raising their price objectives and others adjusting downward. Several firms have upgraded the stock to higher recommendation tiers in recent months, while others maintained a neutral stance. Despite differing views, the consensus reflects broad confidence in the company’s operational stability and sector.
Frequently Asked Questions
- Which sector does Johnson & Johnson operate in?
Johnson & Johnson operates in the healthcare sector. - Which major indices include Johnson & Johnson?
The company is part of the Dow Jones Industrial Average. - How did Johnson & Johnson perform in its latest quarter?
The company reported esp above consensus estimates and year-over-year revenue growth.
